Overview
- Health Ministry draft shifts target dates for adding rotavirus (2029), varicella (2031), HPV (2027) and meningococcal (2027) vaccines to the National Immunization Calendar.
- Under the proposal, vaccines would be included only once full-cycle manufacturing is established in Russia.
- Nanolek reports full-cycle HPV production in the Kirov region, projects over 600,000 doses in 2026 and more than 3 million annually by 2027, and seeks timely changes to 157-FZ and Health Ministry order No. 1122.
- The company warns that a one-year postponement of HPV immunization could push actual state supply to 2028 or beyond, and patient advocates criticize delays as slowing broader protection.
- Separately, Vector reports roughly 80% effectiveness for 2025–2026 influenza vaccines against the circulating H3N2 ‘Hong Kong’ subclade, with ongoing monitoring and expert recommendations to vaccinate high‑risk groups.